Trademark

Who Watches the Watchmen? – Empirically Examining Examination Reports (Part 1)

by
Leave a Comment

We’re very happy to bring our readers a guest post that uses a dataset of more than 300,000 trademark examination reports from the year 2019, as the basis for analysing the trademark registry’s examination process. The importance of having and using data while looking at the functioning of the various IP arms of the government is a point that the blog has often harped upon. The current guest post, by Mohit Yadav, a very tech savvy lawyer and founder of…


Read More »
Others

SpicyIP Fortnightly Review (October 17-31)

by
Leave a Comment

Delhi High Court extends the deadline to submit comments on Delhi High Court Intellectual Property Rights Division Rules, 2021 Praharsh reported that the Delhi High Court Registry announced an extension for submitting suggestions and comments on the proposed Delhi High Court Intellectual Property Rights Division Rules, 2021. The new deadline stands as November 10, 2021. The new Rules are a result of the Tribunal Reforms Act, 2021. Drug Price Controls in the US: Same, Same but Different? I wrote about…


Read More »
Others

Delhi High Court extends the deadline to submit comments on Delhi High Court Intellectual Property Rights Division Rules, 2021

by
Leave a Comment

The Delhi High Court Registry on October 26, 2021 announced an extension for submitting suggestions and comments on the proposed Delhi High Court Intellectual Property Rights Division Rules, 2021. As per this, the new deadline stands as November 10, 2021.  The proposed rules come out as a result of the Tribunal Reforms Act, 2021, and the recommendations made by the committee constituted by the Chief Justice of the Delhi High Court Justice D. N Patel, to further the implementation of…


Read More »
Drug Regulation Innovation

Drug Price Controls in the US: Same, Same but Different?

by
1 Comment

In 2017, when India introduced price controls on coronary stents, the United States Trade Representative (USTR) had requested the Prime Minister to not extend price controls to additional medical devices. When India refused to heed to the request, amongst other things, the National Trade Estimate Report on Foreign Trade Barriers reported the measure of price capping to be without a sense of differentiation between newer and older products (here, p. 235), India’s eligibility for US’ Generalized System of Preferences (GSP)…


Read More »
Opportunities Patent Sponsored

[Sponsored] LexisNexis Webinar on ‘Calling for Action: How to Track and Measure Sustainable Innovation and Investments’ [October 19]

by
Leave a Comment

We’re pleased to bring you this announcement by LexisNexis on their launch of a new Sustainable Innovation Measurement framework to enable organizations globally to objectively track and report on innovation’s contribution to the United Nations Sustainable Development Goals. They are also holding a webinar on ‘Calling for Action: How to Track and Measure Sustainable Innovation and Investments’ on October 19, 2021, the details of which can be viewed below. Introducing a New Objective Way to Track and Measure Sustainable Innovation…


Read More »
Copyright

Strategic Legal Algorithms Against Public Participation: YouTube Disables Newslaundry’s Account Following Copyright Claims from Aaj Tak

by
4 Comments

In a new low for Indian media, Aaj Tak (owned by the media conglomerate Living Media) has allegedly taken to using copyright claims to prevent criticism of its reportage by media watchdog Newslaundry. On October 8, Newslaundry staff revealed that its YouTube operations had been stalled pending an enquiry into 53 separate copyright notices received by YouTube from Aaj Tak. The videos flagged (according to Newslaundry, not independently verified by us) pertained to Newslaundry’s commentary and criticism of Aaj Tak’s…


Read More »
COVID-19 Opportunities

International Webinar on ‘Vaccines and Immunization: Ethical and Legal Implications’ [October 18]

by
Leave a Comment

We’re pleased to inform you that the Centre for Health Law and Policy (CHLP), the Centre for Human Rights (CHR) and the Centre for Intellectual Property Rights (CIPR) under the aegis of the National University of Advanced Legal Studies (NUALS), in collaboration with the Prof. N R Madhava Menon Interdisciplinary Centre for Research Ethics and Protocols (ICREP), CUSAT and the Kerala State Higher Education Council are conducting an international webinar on ‘Vaccines and Immunization: Ethical and Legal Implications’ on October…


Read More »
Copyright Drug Regulation Geographical Indication Patent Trademark

SpicyIP Weekly Review (September 27 – October 3)

by
Leave a Comment

Zolgensma and the Inadequacies of the Compulsory Licensing Regime In a guest post, Akhil wrote about Zolgensma, Novartis’ gene therapy medication prescribed for treatment of Spinal Muscular Atrophy (‘SMA’). Akhil discusses the compulsory licensing provisions in the TRIPS Agreement, as well as the objectives and principles relating to safeguarding public interest in Articles 7 and 8 and how they find reflection in India’s Patent Act. Breaking down the 3 tests of reasonably meeting the requirements of public, reasonable affordability and…


Read More »
Opportunities Traditional Knowledge

Webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ [October 13]

by
Leave a Comment

We are pleased to inform you that the Microsoft IPR Chair and the DPIIT IPR Chair at Gujarat National Law University (GNLU), Gandhinagar are jointly organising a webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ on 13th October, 2021. Webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ We are elated to announce that the Microsoft- IPR Chair-GNLU and DPIIT IPR Chair-GNLU are jointly organising a webinar on “Traditional…


Read More »
Biological Diversity Opportunities

Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing [October 4-7]

by
Leave a Comment

We’re pleased to inform you that the DPIIT IPR Chair of Inter University Centre for Intellectual Property Rights Studies at the Cochin University of Science and Technology (CUSAT) is organizing a four day webinar on “Digital Sequence Information(DSI)- Implications on Access and Benefit Sharing” from October 4-7 2021. For further details, please read the announcement below. Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing The four-day webinar aims to sensitise the legal fraternity about the challenges posed…


Read More »
  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. ...
  13. 590